Filtros de búsqueda

Lista de obras de Shahin Akhondzadeh

A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia

artículo científico publicado en 2008

A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease

artículo científico publicado en 2009

A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders

artículo científico publicado en 2012

A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder

artículo científico publicado en 2007

A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia.

artículo científico publicado en 2013

A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia.

artículo científico publicado en 2010

A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.

artículo científico publicado en 2015

A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression

scientific article published on 10 October 2019

A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.

artículo científico publicado en 2007

A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia

artículo científico publicado en 2011

A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.

artículo científico publicado en 2009

A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients

artículo científico publicado en 2013

Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial

artículo científico publicado en 2011

Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial

artículo científico publicado en 2008

Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial

artículo científico publicado en 2003

Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial

artículo científico publicado en 2007

Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial

artículo científico publicado en 2006

Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive-compulsive disorder: A double-blind randomized trial with placebo control

scientific article published on 25 December 2018

Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial

artículo científico publicado en 2010

Antidepressant-like effect of magnetic resonance imaging-based stimulation in mice.

artículo científico publicado en 2007

Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study

artículo científico publicado en 2013

Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial

artículo científico publicado en 2019

Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial

artículo científico publicado en 2001

Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.

artículo científico publicado en 2004

Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study

artículo científico publicado en 2012

Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial.

artículo científico publicado en 2015

Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial

artículo científico publicado en 2007

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial

artículo científico publicado en 2012

Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial.

artículo científico publicado en 2015

Celecoxib for the treatment of mild-to-moderate depression due to acute brucellosis: a double-blind, placebo-controlled, randomized trial

artículo científico publicado en 2015

Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study

artículo científico publicado en 2017

Citicoline (CDP-choline) add-on therapy to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial

artículo científico publicado en 2018

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.

artículo científico publicado en 2009

Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial

scientific article published on 01 April 1998

Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study

artículo científico publicado en 2014

Comparing the effects of high-dose vitamin E with those of placebo on insulin resistance in patients with schizophrenia treated with olanzapine.

artículo científico publicado en 2009

Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial

artículo científico publicado en 2014

Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]

artículo científico publicado en 2004

Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial

artículo científico publicado en 2003

Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial

artículo científico publicado en 2005

Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial.

artículo científico publicado en 2006

Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double-blind randomized trial

scientific article published on 18 May 2020

Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia

artículo científico publicado en 2006

Correlation of adenosinergic activity with superior efficacy of clozapine for treatment of chronic schizophrenia: a double blind randomised trial

artículo científico publicado en 2011

Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial.

artículo científico publicado en 2006

Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial.

artículo científico publicado en 2008

Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial

artículo científico publicado en 2005

Cyproheptadine for prevention of neuropsychiatric adverse effects of efavirenz: a randomized clinical trial

artículo científico publicado en 2013

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.

artículo científico publicado en 2004

Cyproheptadine in treatment of autism.

artículo científico publicado en 2002

Cyproheptadine in treatment of chronic schizophrenia: a double-blind, placebo-controlled study

artículo científico publicado en 1999

Diazoxide in the treatment of schizophrenia: novel application of potassium channel openers in the treatment of schizophrenia

artículo científico publicado en 2002

Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions

artículo científico publicado en 2000

Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression

artículo científico publicado en 2012

Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression

artículo científico publicado en 2003

Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.

artículo científico publicado en 2009

Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal

artículo científico publicado en 2000

Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.

artículo científico publicado en 2011

Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study

artículo científico publicado en 2013

Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder

artículo científico publicado en 2010

Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania ⬇️

artículo científico publicado el 16 de septiembre de 2010

Effect of Adjunctive Celecoxib on BDNF in Manic Patients Undergoing Electroconvulsive Therapy: a Randomized Double Blind Controlled Trial

artículo científico publicado en 2015

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study

artículo científico publicado en 2012

Effect of omega-3 and ascorbic acid on inflammation markers in depressed shift workers in Shahid Tondgoyan Oil Refinery, Iran: a randomized double-blind placebo-controlled study

artículo científico publicado en 2013

Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

artículo científico publicado en 2008

Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial

artículo científico publicado en 2012

Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: a placebo-controlled, double-blind, randomised study

scientific article published on 19 February 2014

Efficacy and safety of tipepidine as adjunctive therapy in children with attention-deficit/hyperactivity disorder: Randomized, double-blind, placebo-controlled clinical trial

artículo científico publicado en 2019

Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial

artículo científico publicado en 2020

Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial

artículo científico publicado en 2018

Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

artículo científico publicado en 2008

Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial

artículo científico publicado en 2004

Fluticasone propionate in clinically suspected asthma patients with negative methacholine challenge test.

artículo científico publicado en 2015

Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial

artículo científico publicado en 2019

Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial

artículo científico publicado en 2020

Frequency of myasthenic crisis in relation to thymectomy in generalized myasthenia gravis: a 17-year experience

artículo científico publicado en 2004

Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.

artículo científico publicado en 2013

Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.

artículo científico publicado en 2009

Glutamate-independent long term depression in rat hippocampus by activation GABAA receptors.

artículo científico publicado en 1996

Glutathione-related factors and oxidative stress in autism, a review

artículo científico publicado en 2012

Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial

scientific article published on 01 October 2012

Granisetron as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.

artículo científico publicado en 2013

Health-related quality of life of Iranian children with attention deficit/hyperactivity disorder

artículo científico publicado en 2010

Herbal medicine in the treatment of Alzheimer's disease.

artículo científico publicado en 2006

Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial

artículo científico publicado en 2005

Hydroxyzine may be safe and effective in generalised anxiety disorder

scientific article published on 01 August 2003

Interaction between adenosine and GABAA receptors on hippocampal neurones

scientific article published on 01 December 1994

Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial

artículo científico publicado en 2014

Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study

artículo científico publicado en 2013

L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study

artículo científico publicado en 2017

L-lysine as an adjunct to risperidone in patients with chronic schizophrenia: a double-blind, placebo-controlled, randomized trial

artículo científico publicado en 2014

Lipoid proteinosis: phenotypic heterogeneity in Iranian families with c.507delT mutation in ECM1.

artículo científico publicado en 2015

Lovastatin for the adjunctive treatment of schizophrenia: a preliminary randomized double-blind placebo-controlled trial

artículo científico publicado en 2014

Maintenance of muscimol-induced long-term depression by neurosteroids

artículo científico publicado en 1996

Major depressive disorder in children and adolescents after renal transplantation.

artículo científico publicado en 2009

Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial

artículo científico publicado en 2003

Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study.

artículo científico publicado en 2012

Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study.

artículo científico publicado en 2013

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

artículo científico publicado en 2012

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study

artículo científico publicado en 2014

Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial

artículo científico publicado en 2007

Muscimol-induced long-term depression in the hippocampus: lack of dependence on extracellular calcium

artículo científico publicado en 1996

N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study.

artículo científico publicado en 2013

Omega-3 supplementation effects on body weight and depression among dieter women with co-morbidity of depression and obesity compared with the placebo: A randomized clinical trial

artículo científico publicado en 2018

Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive-compulsive disorder

artículo científico publicado en 2014

Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.

artículo científico

Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam

artículo científico publicado en 2001

Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial

artículo científico publicado en 2001

Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches.

artículo científico publicado en 2007

Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial.

artículo científico publicado en 2015

Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.

artículo científico publicado en 2012

Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia

scientific article published on 01 October 1999

Potentiation by neurosteroids of muscimol/adenosine interactions in rat hippocampus

artículo científico publicado en 1995

Potentiation of muscimol-induced long-term depression by benzodiazepines and prevention or reversal by pregnenolone sulfate

artículo científico publicado en 1998

Potentiation of muscimol-induced long-term depression by benzodiazepines but not zolpidem

artículo científico publicado en 2002

Preface

Preface to a supplement to Pharmacy World on the 5TH Symposium of the European Society for the Study of Purine & Pyrimidtne Metabolism in Man (ESSPPMM 1995)

Prevalence of obsessive-compulsive disorder in Iran

artículo científico publicado en 2004

Prevention of muscimol-induced long-term depression by brain-derived neurotrophic factor

scientific article published on 01 October 1999

Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients

artículo científico publicado en 2005

Published research on attention deficit hyperactivity disorder: a comparative analysis of MEDLINE and an Iranian bibliographic database

artículo científico publicado en 2010

Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial

artículo científico publicado en 2014

Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial

scientific article published on 24 May 2020

Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial

artículo científico publicado en 2019

Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial

artículo científico publicado en 2013

Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial

artículo científico publicado en 2018

Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial

artículo científico publicado en 2003

Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial

artículo científico publicado en 2012

Role of melatonin in body weight: A systematic review and meta-analysis.

artículo científico publicado en 2016

Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study

artículo científico publicado en 2012

Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial.

artículo científico publicado en 2010

Saffron, passionflower, valerian and sage for mental health.

artículo científico publicado en 2013

Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial

artículo científico publicado en 2003

Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial

artículo científico publicado en 2013

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

scientific article published on 15 October 2010

Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial

artículo científico publicado en 2015

Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial

artículo científico publicado en 2015

Sudden hearing loss subsequent to diarrhea: what is the missing link?

artículo científico publicado en 2014

Sulforaphane as an adjunctive treatment for irritability in Autism Spectrum Disorder: a randomized, double-blind, placebo-controlled clinical trial

artículo científico publicado en 2020

The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial

artículo científico publicado en 2009

The glutamate hypothesis of schizophrenia

scientific article published on 01 August 1998

Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial

artículo científico publicado en 2015

Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: a randomized double blind placebo controlled clinical trial

artículo científico publicado en 2014

Total antioxidant capacity and malondialdehyde in depressive rotational shift workers

artículo científico publicado en 2013

Variations in thyroidal activity during estrous cycle and natural breeding season in Markhoz goat breeds

artículo científico publicado en 2009

Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial

artículo científico publicado en 2010

Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial

artículo científico publicado en 2020

Vortioxetine effects on quality of life of irritable bowel syndrome patients: A randomized, double-blind, placebo-controlled trial

scientific article published on 05 September 2019

Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]

artículo científico publicado en 2004

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda